{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:50:36Z","timestamp":1777395036471,"version":"3.51.4"},"reference-count":51,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2022,1,4]]},"abstract":"<jats:p>Background: Central nervous system disruption of cholinergic (ACh) signaling, which plays a major role in cognitive processes, is well documented in dementia with Lewy bodies (DLB) and Alzheimer\u2019s disease (AD). The expression of muscarinic ACh receptors type 1 and 4 (CHRM1 and CHRM4) has been reported to be altered in the brain of DLB patients. Objective: We aim to assess the peripheral gene expression of CHRM1 and 4 in DLB as a possible marker as compared to AD and healthy control (HC) subjects. Methods: Peripheral blood mononuclear cells were collected from 21 DLB, 13 AD, and 8 HC matched subjects. RT-PCR was performed to estimate gene expression of CHRM1 and CHRM4. Results: Peripheral CHRM1 expression was higher and CHRM4 was lower in DLB and AD compared to HC, whereas both CHRM1 and CHRM4 levels were higher in AD compared to DLB patients. Receiver operating characteristics curves, with logistic regression analysis, showed that combining peripheral CHRM1 and CHRM4 levels, DLB and AD subjects were classified with an accuracy of 76.0%. Conclusion: Alterations of peripheral CHRM1 and CHRM4 was found in both AD and DLB patients as compared to HC. CHRM1 and CHRM4 gene expression resulted to be lower in DLB patients compared to AD. In the future, peripheral CHRM expression could be studied as a possible marker of neurodegenerative conditions associated with cholinergic deficit and a possible marker of response to acetylcholinesterase inhibitors.<\/jats:p>","DOI":"10.3233\/jad-215285","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T11:23:09Z","timestamp":1637320989000},"page":"323-330","source":"Crossref","is-referenced-by-count":5,"title":["Muscarinic Receptors Expression in the Peripheral Blood Cells Differentiate Dementia with Lewy Bodies from Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"85","author":[{"given":"Marcella","family":"Reale","sequence":"first","affiliation":[{"name":"Department of Innovative Technologies in Medicine and Dentistry, University \u201cG. d\u2019Annunzio\u201d of Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Carrarini","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Imaging and Clinical Sciences, University \u201cG. d\u2019Annunzio\u201d of Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirella","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Imaging and Clinical Sciences, University \u201cG. d\u2019Annunzio\u201d of Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fedele","family":"Dono","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Imaging and Clinical Sciences, University \u201cG. d\u2019Annunzio\u201d of Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Ferri","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Imaging and Clinical Sciences, University \u201cG. d\u2019Annunzio\u201d of Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Di Pietro","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Imaging and Clinical Sciences, University \u201cG. d\u2019Annunzio\u201d of Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Costantini","sequence":"additional","affiliation":[{"name":"Department of Medicine and Aging Sciences, University \u201cG. d\u2019Annunzio\u201d of Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Porreca","sequence":"additional","affiliation":[{"name":"Department of Medical, Oral and Biotechnological Sciences, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Di Nicola","sequence":"additional","affiliation":[{"name":"Department of Medical, Oral and Biotechnological Sciences, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Onofrj","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Imaging and Clinical Sciences, University \u201cG. d\u2019Annunzio\u201d of Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bonanni","sequence":"additional","affiliation":[{"name":"Department of Medicine and Aging Sciences, University \u201cG. d\u2019Annunzio\u201d of Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-215285_ref1","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/jnnp.74.9.1215","article-title":"Performance on the dementia rating scale in Parkinson\u2019s disease with dementia and dementia with Lewy bodies: Comparison with progressive supranuclear palsy and Alzheimer\u2019s disease","volume":"74","author":"Aarsland","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-215285_ref2","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1136\/bmj.2.6150.1457","article-title":"Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia","volume":"2","author":"Perry","year":"1978","journal-title":"Br Med J"},{"key":"10.3233\/JAD-215285_ref3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00002093-199040200-00003","article-title":"Cholinergic and dopaminergic activities in senile dementia of Lewy body type","volume":"4","author":"Perry","year":"1990","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-215285_ref4","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/1531-8249(200012)48:6<868::AID-ANA7>3.0.CO;2-0","article-title":"Delusions associated with elevated muscarinic binding in dementia with Lewy bodies","volume":"48","author":"Ballard","year":"2000","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-215285_ref5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/cne.902750205","article-title":"Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: Observations based on the distribution of acetylcholinesterase and choline acetyltransferase","volume":"275","author":"Mesulam","year":"1988","journal-title":"J Comp Neurol"},{"key":"10.3233\/JAD-215285_ref6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1471-4159.1995.64020749.x","article-title":"Neurochemical correlates of dementia severity in Alzheimer\u2019s disease: Relative importance of the cholinergic deficits","volume":"64","author":"Bierer","year":"1995","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-215285_ref7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/cercor\/6.2.165","article-title":"Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer\u2019s disease","volume":"6","author":"Geula","year":"1996","journal-title":"Cereb Cortex"},{"key":"10.3233\/JAD-215285_ref8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/00003643-199811000-00028","article-title":"Cholinergic mechanisms and cognitive decline","volume":"15","author":"Perry","year":"1998","journal-title":"Eur J Anaesthesiol"},{"key":"10.3233\/JAD-215285_ref9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0197-4580(95)00086-T","article-title":"Differential correlation between Neurochemical deficits, neuropathology, and cognitive status in Alzheimer\u2019s disease","volume":"16","author":"Dournaud","year":"1995","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-215285_ref10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1212\/WNL.0000000000002839","article-title":"Cholinergic and perfusion brain networks in Parkinson disease dementia","volume":"87","author":"Colloby","year":"2016","journal-title":"Neurology"},{"key":"10.3233\/JAD-215285_ref11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/brcg.1995.1255","article-title":"Acetylcholine and hallucinations: Disease-related compared to drug-induced alterations in human consciousness","volume":"28","author":"Perry","year":"1995","journal-title":"Brain Cogn"},{"key":"10.3233\/JAD-215285_ref12","doi-asserted-by":"crossref","unstructured":"Piggott M , Marshall E (1996) Neurochemical correlates of pathological and iatrogenic extrapyramidal symptoms. In Dementia with Lewy Bodies: Clinical, Pathological, and Treatment Issues, Perry RH, McKeith IG, Perry EK, eds. Cambridge University Press, Cambridge, pp. 449\u2013467.","DOI":"10.1017\/CBO9780511601187.040"},{"key":"10.3233\/JAD-215285_ref13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1017\/S1041610298005341","article-title":"Donepezil for treatment of dementia with Lewy bodies: A case series of nine patients","volume":"10","author":"Shea","year":"1998","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-215285_ref14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer\u2019s disease: A review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-215285_ref15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","article-title":"Research criteria for the diagnosis of prodromal dementia with Lewy bodies","volume":"94","author":"McKeith","year":"2020","journal-title":"Neurology"},{"key":"10.3233\/JAD-215285_ref16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nn992","article-title":"Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice","volume":"6","author":"Anagnostaras","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-215285_ref17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12264-019-00341-4","article-title":"Pathological changes to the subcortical visual system and its relationship to visual hallucinations in dementia with Lewy bodies","volume":"35","author":"Erskine","year":"2019","journal-title":"Neurosci Bull"},{"key":"10.3233\/JAD-215285_ref18","doi-asserted-by":"crossref","first-page":"209 LP","DOI":"10.1136\/jnnp.67.2.209","article-title":"Alterations of muscarinic acetylcholine receptor subtypes in diffuse Lewy body disease: Relation to Alzheimer\u2019s disease. , 209 LP \u2013","volume":"67","author":"Shiozaki","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-215285_ref19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-510X(01)00638-4","article-title":"Distribution of M1 muscarinic acetylcholine receptors in the hippocampus of patients with Alzheimer\u2019s disease and dementia with Lewy bodies-an immunohistochemical study","volume":"193","author":"Shiozaki","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-215285_ref20","doi-asserted-by":"crossref","first-page":"fcaa098","DOI":"10.1093\/braincomms\/fcaa098","article-title":"Cholinergic muscarinic M(1)\/M(4) receptor networks in dementia with Lewy bodies","volume":"2","author":"Colloby","year":"2020","journal-title":"Brain Commun"},{"key":"10.3233\/JAD-215285_ref21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0891-0618(03)00002-4","article-title":"Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson\u2019s disease and Alzheimer\u2019s disease","volume":"25","author":"Piggott","year":"2003","journal-title":"J Chem Neuroanat"},{"key":"10.3233\/JAD-215285_ref22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0306-3623(01)00093-3","article-title":"YM905, a novel M3 antagonist, inhibits Ca2+signaling and c-fos gene expression mediated via muscarinic receptors in human T cells","volume":"35","author":"Fujii","year":"2000","journal-title":"Gen Pharmacol"},{"key":"10.3233\/JAD-215285_ref23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0165-5728(01)00435-0","article-title":"Peripheral blood lymphocytes muscarinic cholinergic receptor subtypes in Alzheimer\u2019s disease: A marker of cholinergic dysfunction?","volume":"121","author":"Tayebati","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.3233\/JAD-215285_ref24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(99)00259-1","article-title":"Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines","volume":"266","author":"Sato","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-215285_ref25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2680.1999.00118.x","article-title":"Evaluation of an agonist index: Affinity ratio for compounds active on muscarinic cholinergic M2 receptors","volume":"19","author":"Tayebati","year":"1999","journal-title":"J Auton Pharmacol"},{"key":"10.3233\/JAD-215285_ref26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0165-5728(95)00051-3","article-title":"Identification of m3, m4 and m5 subtypes of muscarinic receptor mRNA in human blood mononuclear cells","volume":"60","author":"Costa","year":"1995","journal-title":"J Neuroimmunol"},{"key":"10.3233\/JAD-215285_ref27","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/114.4.1759","article-title":"An analysis of lymphocyte 3H-N-methil-scopolamine binding in neurological patients: Evidence of altered binding in Alzheimer\u2019s disease","volume":"114","author":"Ferrero","year":"1991","journal-title":"Brain"},{"key":"10.3233\/JAD-215285_ref28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0028-3908(89)90157-3","article-title":"[3H]N-methylscopolamine binding to muscarinic receptors in human peripheral blood lymphocytes: Characterization, localization on T-lymphocyte subsets and age-dependent changes","volume":"28","author":"Eva","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-215285_ref29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0278-5846(86)90005-9","article-title":"Extraneural cholinergic markers in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"10","author":"Adem","year":"1986","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.3233\/JAD-215285_ref30","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/ana.410300616","article-title":"Changes of muscarinic cholinergic binding by lymphocytes in parkinson\u2019s disease with and without dementia","volume":"30","author":"Rabey","year":"1991","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-215285_ref31","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archpsyc.59.10.946","article-title":"Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease","volume":"59","author":"Tiraboschi","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JAD-215285_ref32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JAD-215285_ref33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-215285_ref34","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1212\/WNL.54.8.1616","article-title":"Quantifying fluctuation in dementia with Lewy bodies, Alzheimer\u2019s disease, and vascular dementia","volume":"54","author":"Walker","year":"2000","journal-title":"Neurology"},{"key":"10.3233\/JAD-215285_ref35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5664\/jcsm.2670","article-title":"Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in a community-based sample","volume":"9","author":"Boeve","year":"2013","journal-title":"J Clin Sleep Med"},{"key":"10.3233\/JAD-215285_ref36","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"issue":"5 Suppl 6","key":"10.3233\/JAD-215285_ref37","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1212\/WNL.48.5_Suppl_6.10S","article-title":"The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients","volume":"48","author":"Cummings","year":"1997","journal-title":"Neurology"},{"key":"10.3233\/JAD-215285_ref38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state\u201d. Apractical method for grading the cognitive state of patients for theclinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-215285_ref39","first-page":"77","article-title":"Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g","volume":"97","author":"B\u00f6yum","year":"1968","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"10.3233\/JAD-215285_ref40","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1373\/clinchem.2005.048546","article-title":"Collection and storage of human blood cells for mRNA expression profiling: A 15-month stability study","volume":"51","author":"Marteau","year":"2005","journal-title":"Clin Chem"},{"key":"10.3233\/JAD-215285_ref41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.mam.2005.12.003","article-title":"RNA integrity and the effect on the real-time qRT-PCR performance","volume":"27","author":"Fleige","year":"2006","journal-title":"Mol Aspects Med"},{"key":"10.3233\/JAD-215285_ref42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.3233\/JAD-215285_ref43","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.3233\/JAD-215285_ref44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0889-1591(89)90001-9","article-title":"Cholinergic receptors of lymphocytes","volume":"3","author":"Ma\u015bli\u0144ski","year":"1989","journal-title":"Brain Behav Immun"},{"key":"10.3233\/JAD-215285_ref45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1365-2567.1997.00323.x","article-title":"Identification of nicotinic acetylcholine receptors on lymphocytes in the periphery as well as thymus in mice","volume":"92","author":"Toyabe","year":"1997","journal-title":"Immunology"},{"key":"10.3233\/JAD-215285_ref46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-5728(99)00061-2","article-title":"Relative amountsof mRNA encoding four subtypes of muscarinic receptors(m2\u2013m5) in human peripheral blood mononuclear cells","volume":"97","author":"Bany","year":"1999","journal-title":"JNeuroimmunol"},{"key":"10.3233\/JAD-215285_ref47","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/toxsci\/20.2.210","article-title":"Modulation of muscarinic receptors and acetylcholinesterase activity in lymphocytes and in brain areas following repeated organophosphate exposure in rats","volume":"20","author":"Fitzgerald","year":"1993","journal-title":"Toxicol Sci"},{"key":"10.3233\/JAD-215285_ref48","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0024-3205(98)00131-3","article-title":"Acetylcholine synthesis and muscarinic receptor subtype mRNA expression in T-lymphocytes","volume":"62","author":"Kawashima","year":"1998","journal-title":"Life Sci"},{"key":"10.3233\/JAD-215285_ref49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/diseases9020029","article-title":"Cholinergic modulation of the immune system in neuroinflammatory diseases","volume":"9","author":"Reale","year":"2021","journal-title":"Diseases"},{"key":"10.3233\/JAD-215285_ref50","doi-asserted-by":"crossref","unstructured":"Adem A (1990) Lymphocyte cholinergic receptor changes in Alzheimer\u2019s disease. In Neuropsychopharmacology, Bunney WE, Hippius H, Laakmann G, Schmauss M, eds. Springer, Berlin, Heidelberg, pp. 134\u2013141.","DOI":"10.1007\/978-3-642-74034-3_13"},{"key":"10.3233\/JAD-215285_ref51","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1192\/bjp.bp.114.152736","article-title":"Visual cortical excitability in dementia with Lewy bodies","volume":"208","author":"Taylor","year":"2016","journal-title":"Br J Psychiatry"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-215285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:04:47Z","timestamp":1777370687000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-215285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":51,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-215285","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]}}}